833 related articles for article (PubMed ID: 9356033)
1. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
[TBL] [Abstract][Full Text] [Related]
2. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
3. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group.
Faronato PP; Maioli M; Tonolo G; Brocco E; Noventa F; Piarulli F; Abaterusso C; Modena F; de Bigontina G; Velussi M; Inchiostro S; Santeusanio F; Bueti A; Nosadini R
Diabetologia; 1997 Jul; 40(7):816-23. PubMed ID: 9243103
[TBL] [Abstract][Full Text] [Related]
4. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
5. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
6. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
[TBL] [Abstract][Full Text] [Related]
8. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].
Molitch ME; Steffes MW; Cleary PA; Nathan DM
Kidney Int; 1993 Mar; 43(3):668-74. PubMed ID: 8455366
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
[TBL] [Abstract][Full Text] [Related]
10. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
; Lachin JM; Genuth S; Cleary P; Davis MD; Nathan DM
N Engl J Med; 2000 Feb; 342(6):381-9. PubMed ID: 10666428
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
[TBL] [Abstract][Full Text] [Related]
12. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.
Wadén J; Forsblom C; Thorn LM; Saraheimo M; Rosengård-Bärlund M; Heikkilä O; Hietala K; Ong K; Wareham N; Groop PH;
Diabetes; 2009 Aug; 58(8):1914-20. PubMed ID: 19491208
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
14. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
15. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes Control and Complications Trial Research Group
Diabetes Care; 2000 Aug; 23(8):1084-91. PubMed ID: 10937502
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
[TBL] [Abstract][Full Text] [Related]
17. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.
Hadjadj S; Péan F; Gallois Y; Passa P; Aubert R; Weekers L; Rigalleau V; Bauduceau B; Bekherraz A; Roussel R; Dussol B; Rodier M; Marechaud R; Lefebvre PJ; Marre M;
Diabetes Care; 2004 Nov; 27(11):2661-8. PubMed ID: 15505002
[TBL] [Abstract][Full Text] [Related]
18. Heritability of the severity of diabetic retinopathy: the FIND-Eye study.
Arar NH; Freedman BI; Adler SG; Iyengar SK; Chew EY; Davis MD; Satko SG; Bowden DW; Duggirala R; Elston RC; Guo X; Hanson RL; Igo RP; Ipp E; Kimmel PL; Knowler WC; Molineros J; Nelson RG; Pahl MV; Quade SR; Rasooly RS; Rotter JI; Saad MF; Scavini M; Schelling JR; Sedor JR; Shah VO; Zager PG; Abboud HE;
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3839-45. PubMed ID: 18765632
[TBL] [Abstract][Full Text] [Related]
19. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated features of albuminuria in Koreans with NIDDM.
Lee KU; Park JY; Kim SW; Lee MH; Kim GS; Park SK; Park JS
Diabetes Care; 1995 Jun; 18(6):793-9. PubMed ID: 7555505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
